×
About 21,270 results

ALLMedicine™ Irritable Bowel Syndrome Center

Research & Reviews  9,381 results

The effects of tegaserod, a gastrokinetic agent, on voltage-gated K+ channels in rabbit...
https://doi.org/10.1111/1440-1681.13477
Clinical and Experimental Pharmacology & Physiology; An JR, Jung HS et. al.

Feb 23rd, 2021 - Tegaserod, a gastroprokinetic agent, is used to treat irritable bowel syndrome. Despite its extensive clinical use, little is known about the effects of tegaserod on vascular ion channels, especially K+ channels. Therefore, we examined the effects...

A randomized double-blind placebo-controlled crossover pilot study: Acute effects of th...
https://doi.org/10.1111/nmo.14094
Neurogastroenterology and Motility : the Official Journal... Böhn L, Törnblom H et. al.

Feb 23rd, 2021 - Postprandial symptoms presumably related to intestinal gas production are common in patients with irritable bowel syndrome (IBS). The aim of the study was to assess if oral α-galactosidase is superior to placebo in reducing gastrointestinal (GI) s...

The Impact of the Coronavirus Disease 2019 (COVID-19) pandemic on Irritable Bowel Syndr...
https://doi.org/10.1111/jgh.15466
Journal of Gastroenterology and Hepatology; Quek SXZ, Loo EXL et. al.

Feb 22nd, 2021 - Gastrointestinal manifestations of the COVID-19 pandemic may mimic Irritable Bowel Syndrome (IBS) and social distancing measures may affect IBS patients negatively. We aimed to study the impact of COVID-19 on respondents with self-reported IBS. We...

The Colonic Mucosal MicroRNAs, MicroRNA-219a-5p and MicroRNA-338-3p, are Downregulated ...
https://doi.org/10.1053/j.gastro.2021.02.040
Gastroenterology Mahurkar-Joshi S, Rankin CR et. al.

Feb 22nd, 2021 - Alterations in microRNA (miRNA) and in the intestinal barrier are putative risk factors for irritable bowel syndrome (IBS). We aimed to identify differentially expressed colonic mucosal miRNAs, their targets in IBS compared to healthy controls (HC...

see more →

Guidelines  39 results

ACG Clinical Guideline: Management of Irritable Bowel Syndrome.
https://doi.org/10.14309/ajg.0000000000001036
The American Journal of Gastroenterology; Lacy BE, Pimentel M et. al.

Dec 14th, 2020 - Irritable bowel syndrome (IBS) is a highly prevalent, chronic disorder that significantly reduces patients' quality of life. Advances in diagnostic testing and in therapeutic options for patients with IBS led to the development of this first-ever ...

Ardelyx Receives FDA Approval For Ibsrela® (Tenapanor), An NHE3 Sodium Transport Inhibitor, For The Treatment Of Irritable Bowel Syndrome With Constipation
http://ir.ardelyx.com/news-releases/news-release-details/ardelyx-receives-fda-approval-ibsrelar-tenapanor-nhe3-sodium

Sep 10th, 2019 - Ardelyx, Inc. (NASDAQ: ARDX), a specialized biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with cardiorenal diseases, today announced that the U.S. Food and Drug Administration h...

AGA Technical Review on the Evaluation of Functional Diarrhea and Diarrhea-Predominant ...
https://doi.org/10.1053/j.gastro.2019.06.014
Gastroenterology Carrasco-Labra A, Lytvyn L et. al.

Jul 28th, 2019 - The evaluation of patients with chronic watery diarrhea represents a diagnostic challenge for clinicians because organic causes, including inflammatory bowel disease, microscopic colitis, and chronic infection, must be differentiated from function...

AGA Clinical Practice Guidelines on the Laboratory Evaluation of Functional Diarrhea an...
https://doi.org/10.1053/j.gastro.2019.07.004
Gastroenterology Smalley W, Falck-Ytter C et. al.

Jul 15th, 2019 - AGA Clinical Practice Guidelines on the Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D).|2019|Smalley W,Falck-Ytter C,Carrasco-Labra A,Wani S,Lytvyn L,|standards,diagnosis,etiology,p...

AGA Guideline on the Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D)
https://www.gastrojournal.org/article/S0016-5085(19)41083-4/fulltext?referrer=https%3A%2F%2Fwww.jwatch.org%2Fna49679%2F2019%2F08%2F09%2Ftesting-functional-diarrhea-and-diarrhea-predominant

Jul 10th, 2019 - This document presents the official recommendations of the American Gastroenterological Association (AGA) on the Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) in Adults. The guideline was de...

see more →

Drugs  479 results see all →

Clinicaltrials.gov  10,461 results

The effects of tegaserod, a gastrokinetic agent, on voltage-gated K+ channels in rabbit...
https://doi.org/10.1111/1440-1681.13477
Clinical and Experimental Pharmacology & Physiology; An JR, Jung HS et. al.

Feb 23rd, 2021 - Tegaserod, a gastroprokinetic agent, is used to treat irritable bowel syndrome. Despite its extensive clinical use, little is known about the effects of tegaserod on vascular ion channels, especially K+ channels. Therefore, we examined the effects...

A randomized double-blind placebo-controlled crossover pilot study: Acute effects of th...
https://doi.org/10.1111/nmo.14094
Neurogastroenterology and Motility : the Official Journal... Böhn L, Törnblom H et. al.

Feb 23rd, 2021 - Postprandial symptoms presumably related to intestinal gas production are common in patients with irritable bowel syndrome (IBS). The aim of the study was to assess if oral α-galactosidase is superior to placebo in reducing gastrointestinal (GI) s...

Hyoscyamine sulfate - hyoscyamine sulfate tablet-REMEDYREPACK INC.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=65896eb3-9d3f-4ec5-881f-566500feaa7e

Feb 23rd, 2021 - Hyoscyamine Sulfate Sublingual Tablets are effective as adjunctive therapy in the treatment of peptic ulcer. They can also be used to control gastric secretions, visceral spasm and hypermotility in spastic colitis, spastic bladder, cystitis, pylor...

The Impact of the Coronavirus Disease 2019 (COVID-19) pandemic on Irritable Bowel Syndr...
https://doi.org/10.1111/jgh.15466
Journal of Gastroenterology and Hepatology; Quek SXZ, Loo EXL et. al.

Feb 22nd, 2021 - Gastrointestinal manifestations of the COVID-19 pandemic may mimic Irritable Bowel Syndrome (IBS) and social distancing measures may affect IBS patients negatively. We aimed to study the impact of COVID-19 on respondents with self-reported IBS. We...

see more →

News  881 results

IBD: Fecal Calprotectin's Role in Guiding Treatment Debated
https://www.medscape.com/viewarticle/942441

Dec 9th, 2020 - Questions on fecal calprotectin's usefulness as a measure of intestinal inflammation in inflammatory bowel disease (IBD) dominated the viewer chat after the opening session of Advances in Inflammatory Bowel Diseases 2020 Annual Meeting on Wednesda...

Multidisciplinary Approach Bests Specialist Care for Functional GI Problems
https://www.medscape.com/viewarticle/935117

Aug 4th, 2020 - NEW YORK (Reuters Health) - For patients with irritable bowel syndrome and other functional gastrointestinal disorders, a multidisciplinary team approach was more effective and less costly than gastroenterologist-only care in an open-label, single...

Postcolonoscopy Antibiotics Linked With IBS
https://www.staging.medscape.com/viewarticle/931491

May 31st, 2020 - Antibiotic exposure within 14 days after screening colonoscopy may increase risk of irritable bowel syndrome (IBS), based on a retrospective analysis of more than 400,000 individuals. Antibiotic use in the 2 weeks leading up to colonoscopy also tr...

Postcolonoscopy Antibiotics Linked With IBS
https://www.medscape.com/viewarticle/931491

May 31st, 2020 - Antibiotic exposure within 14 days after screening colonoscopy may increase risk of irritable bowel syndrome (IBS), based on a retrospective analysis of more than 400,000 individuals. Antibiotic use in the 2 weeks leading up to colonoscopy also tr...

Fast Five Quiz: Cannabis Use and Abuse
https://reference.medscape.com/viewarticle/927888_2

Apr 7th, 2020 - Answer 1/5 Although further investigation is still needed, cannabis use currently has the strongest scientific support in treating which of the following? Your peers chose: Irritable bowel syndrome 0% Spasticity associated with multiple sclerosis ...

see more →

Patient Education  29 results see all →